ArticleTrials2015

Effective recruitment of participants to a phase I study using the internet and publicity releases through charities and patient organisations: analysis of the adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D).

James Heywood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.